Optibrium
7221 Cambridge Research Park
Beach Drive
Cambridge
CB25 9TL
United Kingdom
Website: http://www.optibrium.com/
About Optibrium
Optibrium provides elegant software solutions for small molecule design, optimisation and data analysis.YEAR FOUNDED:
2009
LEADERSHIP:
CEO: Matthew Segall
CSO: Edmund Champness
JOBS:
Please click here for Optibrium job opportunities.
PRODUCTS:
All Products
FOLLOW OPTIBRIUM:
Tweets by Optibrium
42 articles with Optibrium
-
Optibrium Expands Operations in North America for AI and Computational Drug Discovery Technologies
10/18/2022
Optibrium, a leading developer of software and artificial intelligence solutions for drug discovery, announced the opening of its US subsidiary, Optibrium Inc., and the promotion of Dr Tamsin Mansley to President of the new subsidiary to lead its US-based team and business operations.
-
Olink said the measurement of proteins at "population scale" provides the ability to improve the understanding of underlying mechanisms of diseases.
-
BioSpace Movers & Shakers, Sept. 24
9/24/2021
Life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers. -
BioSpace Movers & Shakers, Feb. 26
2/26/2021
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
-
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
-
Optibrium and North Carolina School of Science and Mathematics mark five years of education collaboration with summer school ‘Computing COVID-19’
7/9/2020
Optibrium’s StarDrop™ drug discovery software inspires the next generation of high-school students in their challenge to target COVID-19
-
BioSpace Global Roundup, April 2
4/2/2020
Biopharma companies from across the globe provide updates on their pipelines and business practices. -
BioSpace Movers & Shakers, Feb. 21
2/21/2020
Biopharma and life sciences companies strengthen their leadership teams and board with this week's Movers & Shakers. -
Intellegens and Optibrium celebrate success in global challenge to find novel antimalarial compounds
12/3/2019
Successful models selected by Open Source Malaria consortium will be progressed through to design novel compounds for synthesis and testing
-
BioSpace Global Roundup, Nov. 21
11/21/2019
Companies from across the globe provide updates on their businesses and pipelines. -
Optibrium collaborates with Enamine and BioSolveIT to add REAL Space Search Tool to StarDrop
11/19/2019
New extension enables researchers to explore the REAL Space of 11 billion readily accessible compounds directly from StarDrop
-
BioSpace Global Roundup, Oct. 31
10/31/2019
Companies from across the globe share updates to their businesses and pipelines. -
BioSpace Global Roundup, Oct. 17
10/17/2019
Companies from across the globe provide business and pipeline updates. -
Biotech and pharma companies from across Europe and Asia provide updates on pipeline and business activities.
-
BioSpace Movers and Shakers: Feb. 1
2/1/2019
As January ends, biotech and pharma companies tap new leaders to help drive strategic visions. New hires at Histogen, Indalo, Novartis Oncology, Calico, and more. -
Optibrium strengthens senior management team with Financial Director appointment
1/28/2019
Optibrium™, a developer of software for drug discovery, today announced the appointment of Clare Devlin as Financial Director.
-
Optibrium and University of Nottingham Collaborate on Innovative Teaching Programme
11/5/2018
Provides students with the opportunity to design new drug-like molecules targeting fibrotic diseases and malaria with cutting-edge drug discovery software
-
Novel deep learning drug discovery platform gets £1 million innovation boost
9/19/2018
Optibrium, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery
-
Optibrium Expands U.S. and U.K. Operations
1/30/2018
Optibrium today announced it has appointed Dr. Scott Lyon as Director of Business Development and relocated its Headquarters and R&D facilities, to Cambridge Innovation Park, Cambridge, UK.